Publication | Closed Access

A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway

InflammationChronic Inflammatory DiseasesAnti-inflammatoryMucosal ImmunologyPpar-γ-dependent PathwayMedicineImmune RegulationGastroenterologyImmunologyPharmacologyInflammatory DiseaseTnbs-induced Colitis